Christopher R. Fenimore

EVP Finance CFO at Regeneron Pharmaceuticals · 4 reported transactions in 1 company · latest report Aug 18, 2026

Their trades


Regeneron PharmaceuticalsREGN	Shares withheld for tax $3.74M · 4,599 shares	Aug 18, 2026
Regeneron PharmaceuticalsREGN	Exercised options $2.4M · 6,283 shares	Aug 18, 2026
Regeneron PharmaceuticalsREGN	Shares withheld for tax $707.2K · 992 shares	Dec 8, 2025
Regeneron PharmaceuticalsREGN	Share award — · 3,027 shares	Dec 5, 2025

Aug 18, 2026 · REGN

$3.74M

Aug 18, 2026 · REGN

$2.4M

Dec 8, 2025 · REGN

$707.2K

Dec 5, 2025 · REGN

3,027

4 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

EVP Finance CFO at Regeneron Pharmaceuticals · 4 reported transactions in 1 company · latest report Aug 18, 2026


Regeneron PharmaceuticalsREGN	Shares withheld for tax $3.74M · 4,599 shares	Aug 18, 2026
Regeneron PharmaceuticalsREGN	Exercised options $2.4M · 6,283 shares	Aug 18, 2026
Regeneron PharmaceuticalsREGN	Shares withheld for tax $707.2K · 992 shares	Dec 8, 2025
Regeneron PharmaceuticalsREGN	Share award — · 3,027 shares	Dec 5, 2025